Abstract:Electrospun fibrous materials have a wide range of biomedical applications, many of them involving the use of polymers as matrices for incorporation of therapeutic agents. The use of polymer blends improves the tuneability of the physicochemical and mechanical properties of the drug loaded fibers. This also benefits the development of controlled drug release formulations, for which the release rate can be modified by altering the ratio of the polymers in the blend. However, to realize these benefits, a clear understanding of the phase behavior of the processed polymer blend is essential. This study reports an in depth investigation of the impact of the electrospinning process on the phase separation of a model partially miscible polymer blend, PVP K90 and HPMCAS, in comparison to other conventional solvent evaporation based processes including film casting and spin coating. The nanoscale stretching and ultrafast solvent removal of electrospinning lead to an enhanced apparent miscibility between the polymers, with the same blends showing micronscale phase separation when processed using film casting and spin coating. Nanoscale phase separation in electrospun blend fibers was confirmed in the dry state. Rapid, layered, macroscale phase separation of the two polymers occurred during the wetting of the fibers. This led to a biphasic drug release profile from the fibers, with a burst release from PVP-rich phases and a slower, more continuous release from HPMCAS-rich phases. It was noted that the model drug, paracetamol, had more favorable partitioning into the PVP-rich phase, which is likely to be a result of greater hydrogen bonding between PVP and paracetamol. This led to higher drug contents in the PVP-rich phases than the HPMCAS-rich phases. By alternating the proportions of the PVP and HPMCAS, the drug release rate can be modulated.

Mechanism of a Long-Term Controlled Drug Release System Based on Simple Blended Electrospun Fibers

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Electrospinning of Biomacromolecules for Controlled Drug Release

Controlled Release of Antibiotics from Poly‐ε‐caprolactone/polyethylene Glycol Wound Dressing Fabricated by Direct‐writing Melt Electrospinning

Encapsulating Drugs in Biodegradable Ultrafine Fibers Through Co-Axial Electrospinning

Electrospun Fibre Composite for Controlled Drug Release

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

Smart Electrospun Nanofibers for Controlled Drug Release: Recent Advances and New Perspectives

Electrospun Fibers with Blank Surface and Inner Drug Gradient for Improving Sustained Release.

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

Alginate-Based Electrospun Nanofibers and the Enabled Drug Controlled Release Profiles: A Review

Electrospun Polymer Blend Nanofibers for Tunable Drug Delivery: The Role of Transformative Phase Separation on Controlling the Release Rate

Electrospun fibers of acid-labile biodegradable polymers with acetal groups as potential drug carriers.

Controlled Antibiotics Release System through Simple Blended Electrospun Fibers for Sustained Antibacterial Effects.

Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly(l-lactic acid) fiber mats loaded with chitosan microspheres

Ph-Responsive Nanofiber Membranes for Superior Controlled Release of Poorly Water-Soluble Drug and Its Release Mechanism Study

Electrospun Core-Shell Plla Nanofiber And Its Potential For Drug Release

A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles.

Coaxial Electrospun Poly(L‐Lactic Acid) Ultrafine Fibers for Sustained Drug Delivery

Fabrication, Characterization and Drug Release Characteristics of Drug Loaded Poly (L-Lactic Acid) Fiber